A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis

A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis

Introduction: Osteoporosis is a serious condition affecting up to 50% of Indian postmenopausal women. Denosumab reduces bone resorption by targeting the receptor activator of nuclear factor-κB ligand. This study assessed the efficacy and safety of denosumab in Indian postmenopausal women with osteop...

Full description

Bibliographic Details
Main Authors: Shailesh Pitale, Mathew Thomas, Gaurav Rathi, Vaishali Deshmukh, Prasanna Kumar, Sanjay Reddy, Naresh Shetty, Atul Kakar, Sushrut Babhulkar, Bharat Mody, Jacob Chacko, Sudeep Acharya, Sadhna Joglekar, Vipul Halbe, Barbara G Kravitz, Brian Waterhouse, Antonio J Nino, Lorraine A Fitzpatrick
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Bone mineral density
bone turnover markers
denosumab
India
osteoporosis
postmenopausal
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=1;spage=148;epage=154;aulast=Pitale

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=1;spage=148;epage=154;aulast=Pitale

Similar Items